Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia 9Breast Neoplasms 4Wilms Tumor 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Head and Neck Neoplasms 2Congenital Abnormalities 2Unspecified Adult Solid Tumor, Protocol Specific 1Testicular Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Leydig Cell Tumor 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Fatigue 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Dexamethasone 45Bortezomib 21Lenalidomide 19Cyclophosphamide 19daratumumab 16Calcium Dobesilate 13Thalidomide 12Melphalan 11carfilzomib 9Prednisone 7pomalidomide 6Peripheral Blood Stem Cell Transplantation 6Doxorubicin 6Filgrastim 5dexamethasone acetate 4dexamethasone 21-phosphate 4auricularum 4Vincristine 4isatuximab 3Interferon-alpha 3Etoposide 3selinexor 2sargramostim 2ixazomib 2elotuzumab 2cobimetinib 2Steroids 2Radiotherapy 2Microarray Analysis 2Granulocyte Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Multiple Myeloma × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT00899080 2017-05-17

Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide

Eastern Cooperative Oncology Group

Completed
33 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡